Actavia Life Sciences, Inc. (RASP)
OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0095 (-95.00%)
At close: Dec 26, 2025

Actavia Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
01524510
Market Cap Growth
-87.50%603.00%-46.89%-20.00%-50.00%-68.75%
Enterprise Value
-1625611
Last Close Price
0.000.020.010.060.070.15

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
PB Ratio
-0.18-7.89-1.30-1.50-1.934.07

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Debt / Equity Ratio
-0.14-0.11-0.13-0.25-0.190.10
Net Debt / Equity Ratio
-0.14-0.07-0.11-0.24-0.190.09
Net Debt / EBITDA Ratio
---0.47-2.71-0.91-0.24
Net Debt / FCF Ratio
-4.55-15.97-0.58-2.29-2.02-2.32
Quick Ratio
0.000.040.020.000.010.02
Current Ratio
0.020.050.050.020.010.03
Return on Equity (ROE)
------33.19%
Return on Assets (ROA)
-427.68%-2928.18%-369.57%-399.60%-13.97%-11.25%
Return on Capital Employed (ROCE)
15.80%216.70%24.00%9.00%20.80%-36.10%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19
Earnings Yield
-105.37%-28.78%-31.27%-21.19%-103.46%-9.06%
FCF Yield
-17.22%-0.06%-14.24%-7.10%-4.86%-0.90%
Buyback Yield / Dilution
-186.81%-418.75%-61.70%---